Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Cristina Granetto
Discontinuation of First-Line Bevacizumab in Metastatic Colorectal Cancer: The BEAWARE Italian Observational Study
Tumori
Medicine
Cancer Research
Oncology
Related publications
Bevacizumab in First-Line Treatment of Elderly Patients With Metastatic Colorectal Cancer: German Community-Based Observational Cohort Study Results
BMC Cancer
Cancer Research
Oncology
Genetics
Metastatic Colorectal Cancer First-Line Treatment With Bevacizumab: The Impact of K-Ras Mutation
OncoTargets and Therapy
Oncology
Pharmacology
Reply: Capecitabine and Bevacizumab as First-Line Treatment in Elderly Patients With Metastatic Colorectal Cancer
British Journal of Cancer
Cancer Research
Oncology
Cetuximab in First Line Treatment of Metastatic Colorectal Cancer
Farmeconomia. Health economics and therapeutic pathways
A Multicenter Clinical Phase II Study of FOLFOXIRI Plus Bevacizumab as First-Line Therapy in Patients With Metastatic Colorectal Cancer: QUATTRO Study
Clinical Colorectal Cancer
Oncology
Gastroenterology
The ‘Real-Life’ Impact of Adding Bevacizumab to First-Line Therapy in Metastatic Colorectal Cancer Patients: A Large Israeli Retrospective Cohort Study
Acta Oncologica
Nuclear Medicine
Radiology
Hematology
Oncology
Medicine
Imaging
The Addition of Bevacizumab in the First-Line Treatment for Metastatic Colorectal Cancer: An Updated Meta-Analysis of Randomized Trials
Oncotarget
Oncology
190P Observational Cohort Study of 1st Line Bevacizumab Combined With Chemotherapy in Metastatic Colorectal Cancer (HGCSG0802): Sub-Group Analysis by the Glasgow Prognostic Score (GPS)
Annals of Oncology
Medicine
Oncology
Hematology
Clinical Relevance of Alternative Endpoints in Colorectal Cancer First-Line Therapy With Bevacizumab: A Retrospective Study
Clinical Colorectal Cancer
Oncology
Gastroenterology
